Jefferies Lowers ENZY Target Price

Monday, May 19, 2014, Jefferies reported in a morning report it was Lowering

to a price target to $14.50 from $25. Jefferies analyst Laurence Alexander stated that they expect shares to be range-bound for now, and with significant near-term volatility and uncertainty, Alexander lowered the price target. Alexander states, "Our $14.50 (down from $25) price target is based on a sector regression, SOTP and DCF models and implies Enzymotec trades at 12.6x 2015E EPS and 8.2x EBITDA." ENZY shares are trading at 15.2x 2014 expected EPS and 9.6x EBITDA. ENZY shares were up 4% from the previous close of 12.90 to 13.42 at 11:08AM EDT.